Shares of Cantel Medical Corp. (NYSE:CMD) hit a new 52-week high on Tuesday . The company traded as high as $111.26 and last traded at $110.18, with a volume of 103300 shares changing hands. The stock had previously closed at $108.30.

The company has a market capitalization of $4,650.00, a P/E ratio of 61.39 and a beta of 1.25. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.48 and a current ratio of 2.44.

Cantel Medical (NYSE:CMD) last announced its earnings results on Thursday, December 7th. The company reported $0.57 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.05. Cantel Medical had a return on equity of 17.42% and a net margin of 9.50%. analysts anticipate that Cantel Medical Corp. will post 2.35 earnings per share for the current fiscal year.

The firm also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Wednesday, January 17th will be paid a $0.085 dividend. The ex-dividend date is Tuesday, January 16th. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a dividend yield of 0.17%. Cantel Medical’s dividend payout ratio (DPR) is 7.73%.

In other news, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction on Friday, October 20th. The stock was sold at an average price of $97.55, for a total value of $279,773.40. Following the completion of the sale, the executive vice president now directly owns 39,102 shares in the company, valued at $3,814,400.10. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 12.30% of the company’s stock.

A number of hedge funds have recently made changes to their positions in CMD. Schwab Charles Investment Management Inc. acquired a new stake in Cantel Medical in the second quarter worth about $14,782,000. First Trust Advisors LP acquired a new stake in Cantel Medical in the second quarter worth about $852,000. SG Americas Securities LLC acquired a new stake in Cantel Medical in the second quarter worth about $230,000. Swiss National Bank acquired a new stake in Cantel Medical in the second quarter worth about $4,897,000. Finally, JPMorgan Chase & Co. acquired a new stake in Cantel Medical in the second quarter worth about $2,303,000. Hedge funds and other institutional investors own 85.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Cantel Medical (CMD) Hits New 52-Week High at $111.26” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark laws. The legal version of this news story can be read at https://www.watchlistnews.com/cantel-medical-cmd-hits-new-52-week-high-at-111-26/1809707.html.

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.